We are dedicated

to develop drugs for neurological disorders

 

Neuronax is a biopharmaceutical company dedicated to develop first-in-class disease-modifying drugs to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs.

 

Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders.

 

NX210, our lead product is a first-in-class multi-target peptide with high potential in many CNS disorders, as demonstrated via its distinctive and multifunctional mechanism of action on neural cells, encompassing:

– Neuroprotection with strong anti-oxidative properties & anti-apoptotic activities

– Regenerative & remodeling properties including neurite outgrowth to restore lost function

– Cellular plasticity mechanisms